Adjustable glaucoma implant
US-9125723-B2 · Sep 8, 2015 · US
US10195079B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-10195079-B2 |
| Application number | US-201615157240-A |
| Country | US |
| Kind code | B2 |
| Filing date | May 17, 2016 |
| Priority date | Feb 19, 2013 |
| Publication date | Feb 5, 2019 |
| Grant date | Feb 5, 2019 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
Methods and devices for adjusting or configuring the flow rate of an intraocular shunt are provided whereby hypotony can be avoided by increasing the flow rate through the device. In some embodiments, the device is a shunt that can have a first flow that can be modified to a second flow by modifying the shunt, such as by cutting the shunt. Additionally, one or more dissolvable portions can be present to provide an initial flow restriction and subsequent increase in flow over time.
Opening claim text (preview).
What is claimed is: 1. A shunt for draining fluid from an anterior chamber of an eye, the shunt comprising: a main section having an inlet, an outlet, and a wall defining a lumen with a first cross-sectional area and being configured to direct the fluid from the anterior chamber through the inlet toward the outlet such that, when positioned in the eye, fluid is released through the outlet at a location having lower pressure than the anterior chamber; a first detachable flow restriction section, positioned at the outlet, in fluid communication with the main section, the first detachable flow restriction section having a second cross-sectional area that is less that the first cross-sectional area; a second, permanent, detachable flow restriction section, positioned at the inlet, in fluid communication with the main section, the second detachable flow restriction section having a third cross-sectional area that is less that the first cross-sectional area, the second detachable flow restriction section being severable to adjust a flow of fluid through the shunt; and a pharmaceutical or biological agent deliverable to the eye. 2. The shunt of claim 1 , wherein the main section is formed from a separate material from the first and second detachable flow restriction sections. 3. The shunt of claim 1 , wherein the first detachable flow restriction section is dissolvable. 4. The shunt of claim 1 , wherein the first detachable flow restriction section comprises first and second portions that are concentrically layered within the lumen. 5. The shunt of claim 1 , wherein the first detachable flow restriction section comprises first and second portions, the first portion having a first dissolution rate, and the second portion having a second dissolution rate different from the first dissolution rate. 6. The shunt of claim 1 , wherein the first or second detachable flow restriction section comprises the pharmaceutical or biological agent. 7. The shunt of claim 1 , wherein the pharmaceutical or biological agent comprises a coating on an exterior surface of the main section. 8. The shunt of claim 1 , wherein the pharmaceutical or biological agent comprises a coating on an interior surface of the main section. 9. The shunt of claim 1 , wherein a portion of the shunt is impregnated with the pharmaceutical or biological agent. 10. The shunt of claim 1 , wherein the pharmaceutical or biological agent comprises a time-release pharmaceutical or biological agent. 11. The shunt of claim 1 , wherein the second, permanent, detachable flow restriction section comprises a cross-linked gelatin. 12. The shunt of claim 11 , wherein the second, permanent, detachable flow restriction section comprises a cross-linked gelatin subjected to a crosslinker.
Materials for coatings · CPC title
Biologically active materials, e.g. therapeutic substances {(A61L31/047 takes precedence)} · CPC title
Apparatus for modifying intraocular pressure, e.g. for glaucoma treatment (drainage implants in general A61M27/002) · CPC title
Eyes · CPC title
Implant devices for drainage of body fluids from one part of the body to another (intraocular A61F9/00781; middle ear A61F11/202) · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.